Community Healthcare Trust (CHCT) Touches $26.41 High on Jun, 19; CELLCEUTIX CORPORATION (CTIX) SI Increased By 18.47%

June 19, 2017 - By Hazel Jackson

CELLCEUTIX CORPORATION (OTCMKTS:CTIX) had an increase of 18.47% in short interest. CTIX’s SI was 1.04M shares in June as released by FINRA. Its up 18.47% from 875,700 shares previously. With 354,500 avg volume, 3 days are for CELLCEUTIX CORPORATION (OTCMKTS:CTIX)’s short sellers to cover CTIX’s short positions. About 64,935 shares traded. Innovation Pharmaceuticals Inc (OTCMKTS:IPIX) has 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

The stock of Community Healthcare Trust Inc (NYSE:CHCT) reached all time high today, Jun, 19 and still has $27.99 target or 6.00% above today’s $26.41 share price. This indicates more upside for the $355.14 million company. This technical setup was reported by If the $27.99 PT is reached, the company will be worth $21.31M more. About 14,280 shares traded. Community Healthcare Trust Inc (NYSE:CHCT) has risen 34.78% since June 19, 2016 and is uptrending. It has outperformed by 18.08% the S&P500.

Innovation Pharmaceuticals Inc., formerly Cellceutix Corporation, is a clinical-stage biopharmaceutical company. The company has market cap of $93.64 million. The Firm is engaged in developing therapies with oncology, dermatology and antimicrobial applications. It currently has negative earnings. The Firm owns the rights to various drug compounds, including Kevetrin , which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics.

Community Healthcare Trust Incorporated is an integrated healthcare real estate company. The company has market cap of $355.14 million. The Firm owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. It has a 95.34 P/E ratio. It has investments in healthcare real estate, including mortgage and other loans.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: